|
FAM10A4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6286999998959E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73230000000135E-06 |
| Normal-vs-Stage2 |
9.819700E-04 |
| Normal-vs-Stage3 |
2.71659999995233E-06 |
| Normal-vs-Stage4 |
3.21999999997047E-06 |
| Stage1-vs-Stage2 |
8.886200E-01 |
| Stage1-vs-Stage3 |
6.729200E-01 |
| Stage1-vs-Stage4 |
3.502600E-01 |
| Stage2-vs-Stage3 |
6.846400E-01 |
| Stage2-vs-Stage4 |
4.110400E-01 |
| Stage3-vs-Stage4 |
5.624000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3946999999348E-07 |
| Normal-vs-AfricanAmerican |
8.787700E-02 |
| Normal-vs-Asian |
3.69669999999989E-05 |
| Caucasian-vs-AfricanAmerican |
1.113240E-01 |
| Caucasian-vs-Asian |
7.627000E-01 |
| AfricanAmerican-vs-Asian |
1.266380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06789999998469E-06 |
| Normal-vs-Female |
8.56240000013386E-07 |
| Male-vs-Female |
2.954000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.87119999999608E-05 |
| Normal-vs-Age(41-60Yrs) |
5.54560000032289E-07 |
| Normal-vs-Age(61-80Yrs) |
9.80489999968803E-07 |
| Normal-vs-Age(81-100Yrs) |
9.998800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.991600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.298600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.769200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.413600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.500200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.295000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.886400E-01 |
| Classical-VS-Follicular |
2.864000E-02 |
| Classical-VS-Other |
3.235200E-01 |
| Classical-VS-Normal |
1.63845999999745E-05 |
| Tall-VS-Follicular |
1.301830E-01 |
| Tall-VS-Other |
3.463600E-01 |
| Tall-VS-Normal |
3.319400E-03 |
| Follicular-VS-Other |
9.006400E-01 |
| Follicular-VS-Normal |
1.0929000000548E-06 |
| Other-VS-Normal |
1.334370E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76499999948732E-07 |
| Normal-vs-N1 |
3.51459999992088E-07 |
| N0-vs-N1 |
2.613400E-01 |
|
|
